Lawrence Faziola

TL;DR: These conversion equations may aid in the comparison of medication efficacy studies, in meta- and mega-analyses examining symptoms as moderator variables, and in retrospective combination of symptom data in multi-center data sharing projects that need to pool symptom rating data when such data are obtained using different scales.

TL;DR: In this paper, the authors employed the harmonized ENIGMA shape analysis protocols to collaboratively investigate subcortical brain structure shape differences between individuals with schizophrenia and healthy control participants.

TL;DR: This study investigated the potential immediate short-term adverse effect of right unilateral ECT on cognitive function using digital ascending number tapping test (DANTT) as a novel psychometric measurement modality and concluded that ECT does not significantly alter cognitive performance in those domains up to 2 hours after receiving therapy, which is in stark contrast to the results of previous investigations.

TL;DR: This case report describes and reviews a case of olanzapine-induced neutropenia in a schizophrenic patient and attempts to discuss current theories as well as supply evidence in literature of this rare but potentially dangerous adverse effect.

TL;DR: While there is a degree of non-overlap, several negative symptoms scores reflect measures of similar constructs and may be reliably converted between some scales and should be used for meta- and mega-analyses that examine negative symptoms.